TARGETed Therapy Drug MONITOring in DIGestive Oncology

ABSTRACT: Targeted therapy drug monitoring in digestive oncology: Dosage of plasma levels of various multikinase inhibitors (MKI) in patients treated for advanced digestive cancer (gastrointestinal stromal tumor (GIST), metastatic colorectal cancer (mCRC), hepatocellular carcinoma (HCC), gastroenteropancreatic neuroendocrine tumor (gepNET), or pancreatic neuroendocrine tumor (pNET)), with the aim of determine the optimal dose adapted for each patient, in the future.

DISEASE(S): Neuroendocrine Tumors,Metastatic Colorectal Cancer,Gist,Gastrointestinal Neoplasms,Digestive Cancer,Hepatocellular Carcinoma

PROVIDER: 2739807 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR